Kristina Eisinger

2.2k total citations
44 papers, 1.2k citations indexed

About

Kristina Eisinger is a scholar working on Epidemiology, Molecular Biology and Physiology. According to data from OpenAlex, Kristina Eisinger has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 16 papers in Molecular Biology and 14 papers in Physiology. Recurrent topics in Kristina Eisinger's work include Liver Disease Diagnosis and Treatment (18 papers), Adipokines, Inflammation, and Metabolic Diseases (17 papers) and Adipose Tissue and Metabolism (14 papers). Kristina Eisinger is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Adipokines, Inflammation, and Metabolic Diseases (17 papers) and Adipose Tissue and Metabolism (14 papers). Kristina Eisinger collaborates with scholars based in Germany, United States and Switzerland. Kristina Eisinger's co-authors include Christa Buechler, Sabrina Krautbauer, Charalampos Aslanidis, Gerhard Liebisch, Thomas S. Weiß, Gerd Schmitz, Josef Wanninger, Sabrina Bauer, Markus Neumeier and Andréas Schäffler and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Kristina Eisinger

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Eisinger Germany 21 586 422 317 149 140 44 1.2k
Priya Handa United States 18 676 1.2× 930 2.2× 285 0.9× 168 1.1× 167 1.2× 25 2.0k
Elyisha A. Hanniman Canada 7 549 0.9× 334 0.8× 370 1.2× 136 0.9× 131 0.9× 8 1.1k
Jinglong Zhang China 13 244 0.4× 420 1.0× 369 1.2× 74 0.5× 92 0.7× 31 929
Benny Chang United States 17 444 0.8× 781 1.9× 452 1.4× 103 0.7× 379 2.7× 23 1.6k
Eijiro Watanabe Japan 15 561 1.0× 620 1.5× 499 1.6× 145 1.0× 196 1.4× 18 1.5k
Enpeng Zhao China 17 616 1.1× 547 1.3× 152 0.5× 43 0.3× 175 1.3× 27 1.3k
Alexander Sigrüener Germany 15 251 0.4× 598 1.4× 234 0.7× 102 0.7× 161 1.1× 23 999
Nuttaporn Wongsiriroj United States 13 437 0.7× 868 2.1× 337 1.1× 348 2.3× 222 1.6× 15 1.8k
Froogh Darakhshan United Kingdom 13 330 0.6× 294 0.7× 386 1.2× 112 0.8× 134 1.0× 16 883
Toshiaki Teratani Japan 18 539 0.9× 354 0.8× 133 0.4× 56 0.4× 159 1.1× 37 1.1k

Countries citing papers authored by Kristina Eisinger

Since Specialization
Citations

This map shows the geographic impact of Kristina Eisinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Eisinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Eisinger more than expected).

Fields of papers citing papers by Kristina Eisinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Eisinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Eisinger. The network helps show where Kristina Eisinger may publish in the future.

Co-authorship network of co-authors of Kristina Eisinger

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Eisinger. A scholar is included among the top collaborators of Kristina Eisinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Eisinger. Kristina Eisinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eisinger, Kristina, et al.. (2023). Adipose tissue depot specific expression and regulation of fibrosis-related genes and proteins in experimental obesity. Mammalian Genome. 35(1). 13–30. 4 indexed citations
2.
Haberl, Elisabeth M., Rebekka Pohl, Lisa Rein‐Fischboeck, et al.. (2018). Ex vivo analysis of serum chemerin activity in murine models of obesity. Cytokine. 104. 42–45. 22 indexed citations
3.
Eisinger, Kristina, Lisa Rein‐Fischboeck, Markus Neumeier, et al.. (2018). Alpha-syntrophin deficient mice are protected from adipocyte hypertrophy and ectopic triglyceride deposition in obesity. Experimental and Molecular Pathology. 104(3). 212–221. 8 indexed citations
4.
Pohl, Rebekka, Lisa Rein‐Fischboeck, Doris Schacherer, et al.. (2016). Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis. Cytokine. 85. 45–50. 9 indexed citations
5.
Krautbauer, Sabrina, Kristina Eisinger, Reiner Wiest, Gerhard Liebisch, & Christa Buechler. (2016). Systemic saturated lysophosphatidylcholine is associated with hepatic function in patients with liver cirrhosis. Prostaglandins & Other Lipid Mediators. 124. 27–33. 25 indexed citations
6.
Buechler, Christa, Sabrina Krautbauer, & Kristina Eisinger. (2015). Adipose tissue fibrosis. World Journal of Diabetes. 6(4). 548–548. 113 indexed citations
7.
Eisinger, Kristina, Stanley C. Froehner, Marvin E. Adams, Sabrina Krautbauer, & Christa Buechler. (2015). Evaluation of the specificity of four commercially available antibodies to alpha-syntrophin. Analytical Biochemistry. 484. 99–101. 5 indexed citations
8.
Rein‐Fischboeck, Lisa, Sabrina Krautbauer, Kristina Eisinger, et al.. (2015). Hepatic scavenger receptor BI is associated with type 2 diabetes but unrelated to human and murine non-alcoholic fatty liver disease. Biochemical and Biophysical Research Communications. 467(2). 377–382. 13 indexed citations
9.
Pohl, Rebekka, et al.. (2015). Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis. Experimental and Molecular Pathology. 98(2). 295–299. 17 indexed citations
10.
Krautbauer, Sabrina, Kristina Eisinger, Markus Neumeier, et al.. (2014). Free Fatty Acids, Lipopolysaccharide and IL-1α Induce Adipocyte Manganese Superoxide Dismutase Which Is Increased in Visceral Adipose Tissues of Obese Rodents. PLoS ONE. 9(1). e86866–e86866. 21 indexed citations
11.
Krautbauer, Sabrina, et al.. (2014). Manganese superoxide dismutase knock-down in 3T3-L1 preadipocytes impairs subsequent adipogenesis. Molecular and Cellular Biochemistry. 393(1-2). 69–76. 12 indexed citations
12.
Krautbauer, Sabrina, Markus Neumeier, Kristina Eisinger, et al.. (2013). LDL but not HDL increases adiponectin release of primary human adipocytes. Experimental and Molecular Pathology. 95(3). 325–329. 8 indexed citations
13.
Krautbauer, Sabrina, Kristina Eisinger, Madeleine Lupke, et al.. (2013). Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease. Experimental and Molecular Pathology. 95(3). 330–335. 34 indexed citations
14.
Neumeier, Markus, Sabrina Krautbauer, Sandra Schmidhofer, et al.. (2013). Adiponectin receptor 1 C-terminus interacts with PDZ-domain proteins such as syntrophins. Experimental and Molecular Pathology. 95(2). 180–186. 4 indexed citations
15.
Bauer, Sabrina, Kristina Eisinger, Reiner Wiest, et al.. (2012). Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury. Regulatory Peptides. 179(1-3). 10–14. 9 indexed citations
16.
Bauer, Sabrina, Margarita Bala, Andrea Kopp, et al.. (2012). Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo. European Journal of Clinical Investigation. 42(11). 1213–1220. 24 indexed citations
17.
Wanninger, Josef, Gerhard Liebisch, Gerd Schmitz, et al.. (2012). Lipidomic analysis of the liver identifies changes of major and minor lipid species in adiponectin deficient mice. Experimental and Molecular Pathology. 94(2). 412–417. 6 indexed citations
18.
Wanninger, Josef, Sabrina Bauer, Kristina Eisinger, et al.. (2011). Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver. Molecular and Cellular Endocrinology. 349(2). 248–254. 47 indexed citations
19.
Wanninger, Josef, Roland B. Walter, Sabrina Bauer, et al.. (2011). MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis. Experimental and Molecular Pathology. 91(2). 603–607. 27 indexed citations
20.
Neumeier, Markus, Sabrina Bauer, Hilke Brühl, et al.. (2011). Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes. Cytokine. 56(3). 573–580. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priya Handa Breakdown of academic impact, for papers by Elyisha A. Hanniman Breakdown of academic impact, for papers by Jinglong Zhang Breakdown of academic impact, for papers by Benny Chang Breakdown of academic impact, for papers by Eijiro Watanabe Breakdown of academic impact, for papers by Enpeng Zhao Breakdown of academic impact, for papers by Alexander Sigrüener Breakdown of academic impact, for papers by Nuttaporn Wongsiriroj Breakdown of academic impact, for papers by Froogh Darakhshan Breakdown of academic impact, for papers by Toshiaki Teratani
Rankless by CCL
2026